BRUSSELS, Jan. 29 (Xinhua) -- The European Commission granted conditional marketing authorization for the COVID-19 vaccine developed by British company AstraZeneca and Oxford University on Friday, although the bloc seems unlikely to get the amount of doses as agreed for the moment.
"Securing safe vaccines for Europeans is our utmost priority. With the AstraZeneca vaccine now authorized, 400 million additional doses will be available in Europe," said European Commission President Ursula von der Leyen.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
